Innovotech Inc. is dedicated to delivering value to our investors through innovative technologies and a robust portfolio of services in product development and research.
IOT Notice of Annual Meeting (AGS) and Annual Information Circular 2026
Request for Financial Statement (Beneficial Holders)
Consolidated Financial Statements and MD&A for December 31, 2025 and 2024
Financial Statements
Accompanying MD&A
As a diversified technology firm, Innovotech Inc. operates across several key sectors, including the production and sale of laboratory consumables, as well as the development of cutting-edge solutions for various applications. Our operations are streamlined through specialized subsidiaries: Innovotech Labs Corporation (ILC), recognized for its established antimicrobial contract services and trusted by numerous global medical device companies, and Keystone Labs (KLI), a boutique analytical and microbiology service provider catering to clients in the pharmaceutical and biotechnology sectors.
Additionally, Innovotech holds a 60% interest in NouLife Sciences Inc. (NSI), which specializes in valuable intellectual property related to linked antioxidant molecules utilized in skincare and medical treatments. As a publicly listed company on the TSX Venture Exchange under the symbol IOT, we prioritize transparency with our stakeholders while actively pursuing growth and innovation in our field.
